Clinical Trials Directory

Trials / Sponsors / MEI Pharma, Inc.

MEI Pharma, Inc.

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
TerminatedME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Colorectal Cancer
Phase 12023-08-07
WithdrawnRituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
CLL
Phase 22022-11-22
TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma
Phase 32021-08-13
TerminatedZandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or Mor
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma
Phase 22019-06-25
TerminatedA Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML
Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL)
Phase 12018-05-31
TerminatedA Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL)
Phase 12016-10-01
CompletedAssessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of
Malignancies
Phase 12015-06-29
TerminatedME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
Solid Tumors
Phase 1 / Phase 22014-04-01
CompletedDose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors
Solid Tumors
Phase 12012-05-01
CompletedPhase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid T
Solid Tumors
Phase 12011-09-01
CompletedA Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer
Prostate Cancer
Phase 22007-11-01
CompletedOVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patie
Fallopian Tube Cancer, Peritoneal Neoplasms, Ovarian Cancer
Phase 32006-10-01
CompletedPhenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallop
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Phase 1 / Phase 22004-08-01